Literature DB >> 22781099

Identification of homozygous WFS1 mutations (p.Asp211Asn, p.Gln486*) causing severe Wolfram syndrome and first report of male fertility.

Amirreza Haghighi1, Alireza Haghighi, Aria Setoodeh, Nasrollah Saleh-Gohari, Dewi Astuti, Timothy G Barrett.   

Abstract

Wolfram syndrome (WFS) is a neurodegenerative genetic condition characterized by juvenile-onset of diabetes mellitus and optic atrophy. We studied clinical features and the molecular basis of severe WFS (neurodegenerative complications) in two consanguineous families from Iran. A clinical and molecular genetic investigation was performed in the affected and healthy members of two families. The clinical diagnosis of WFS was confirmed by the existence of diabetes mellitus and optic atrophy in the affected patients, who in addition had severe neurodegenerative complications. Sequencing of WFS1 was undertaken in one affected member from each family. Targeted mutations were tested in all members of relevant families. Patients had most of the reported features of WFS. Two affected males in the first family had fathered unaffected children. We identified two homozygous mutations previously reported with apparently milder phenotypes: family 1: c.631G>A (p.Asp211Asn) in exon 5, and family 2: c.1456C>T (p.Gln486*) in exon 8. Heterozygous carriers were unaffected. This is the first report of male Wolfram patients who have successfully fathered children. Surprisingly, they also had almost all the complications associated with WFS. Our report has implications for genetic counseling and family planning advice for other affected families.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781099      PMCID: PMC3573194          DOI: 10.1038/ejhg.2012.154

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  37 in total

1.  Endoplasmic reticulum stress and N-glycosylation modulate expression of WFS1 protein.

Authors:  Suguru Yamaguchi; Hisamitsu Ishihara; Akira Tamura; Takahiro Yamada; Rui Takahashi; Daisuke Takei; Hideki Katagiri; Yoshitomo Oka
Journal:  Biochem Biophys Res Commun       Date:  2004-12-03       Impact factor: 3.575

2.  The relation of spinal cord diseases to gynecomastia and testicular atrophy.

Authors:  I S COOPER; E H RYNEARSON; A A BAILEY; C S MacCARTY
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-06-07

3.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome).

Authors:  H Inoue; Y Tanizawa; J Wasson; P Behn; K Kalidas; E Bernal-Mizrachi; M Mueckler; H Marshall; H Donis-Keller; P Crock; D Rogers; M Mikuni; H Kumashiro; K Higashi; G Sobue; Y Oka; M A Permutt
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

4.  Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome?

Authors:  F C Fraser; T Gunn
Journal:  J Med Genet       Date:  1977-06       Impact factor: 6.318

5.  WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain.

Authors:  K Takeda; H Inoue; Y Tanizawa; Y Matsuzaki; J Oba; Y Watanabe; K Shinoda; Y Oka
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

6.  Male mice with deleted Wolframin (Wfs1) gene have reduced fertility.

Authors:  Klari Noormets; Sulev Kõks; Ants Kavak; Andres Arend; Marina Aunapuu; Aivi Keldrimaa; Eero Vasar; Vallo Tillmann
Journal:  Reprod Biol Endocrinol       Date:  2009-08-10       Impact factor: 5.211

7.  Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay.

Authors:  Alessia Colosimo; Valentina Guida; Luciana Rigoli; Chiara Di Bella; Alessandro De Luca; Silvana Briuglia; Liborio Stuppia; Damiano Carmelo Salpietro; Bruno Dallapiccola
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

8.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.

Authors:  T M Strom; K Hörtnagel; S Hofmann; F Gekeler; C Scharfe; W Rabl; K D Gerbitz; T Meitinger
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

Review 9.  Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease.

Authors:  Kim Cryns; Theru A Sivakumaran; Jody M W Van den Ouweland; Ronald J E Pennings; Cor W R J Cremers; Kris Flothmann; Terry-Lynn Young; Richard J H Smith; Marci M Lesperance; Guy Van Camp
Journal:  Hum Mutat       Date:  2003-10       Impact factor: 4.878

10.  Wolfram Syndrome presenting with optic atrophy and diabetes mellitus: two case reports.

Authors:  Masoud Reza Manaviat; Maryam Rashidi; Seyed Mohammad Mohammadi
Journal:  Cases J       Date:  2009-12-19
View more
  4 in total

1.  Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss.

Authors:  Qinjun Wei; Hongmei Zhu; Xuli Qian; Zhibin Chen; Jun Yao; Yajie Lu; Xin Cao; Guangqian Xing
Journal:  J Transl Med       Date:  2014-11-12       Impact factor: 5.531

2.  A mutant wfs1 zebrafish model of Wolfram syndrome manifesting visual dysfunction and developmental delay.

Authors:  G Cairns; F Burté; R Price; E O'Connor; M Toms; R Mishra; M Moosajee; A Pyle; J A Sayer; P Yu-Wai-Man
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

3.  A Challenging Form of Non-autoimmune Insulin-Dependent Diabetes in a Wolfram Syndrome Patient with a Novel Sequence Variant.

Authors:  Liliana P Paris; Yoshihiko Usui; Josefina Serino; Joaquim Sá; Martin Friedlander
Journal:  J Diabetes Metab       Date:  2015-06

4.  Identification of a novel WFS1 homozygous nonsense mutation in Jordanian children with Wolfram syndrome.

Authors:  Khaldon Bodoor; Osama Batiha; Ayman Abu-Awad; Khaldon Al-Sarihin; Haya Ziad; Yousef Jarun; Aya Abu-Sheikha; Sara Abu Jalboush; Khoulod S Alibrahim
Journal:  Meta Gene       Date:  2016-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.